SMTL ID : 9ix1.1

Crystal structure of the mouse RIP3 kinase domain in complexed with PP2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.31 Å

Oligo State

homo-dimer

Ligands

2 x PP2: 1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE(Non-covalent)

PP2.1: 13 residues within 4Å: Chain A: K.30, V.36, A.49, K.51, E.61, M.65, L.74, L.93, T.95, R.96, F.97, M.98, L.150 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:K.51, A:K.51, A:L.74, A:T.95, A:L.150, A:L.150 Hydrogen bonds: A:T.95, A:R.96, A:M.98 PP2.2: 14 residues within 4Å: Chain B: V.28, K.30, G.31, V.36, A.49, K.51, E.61, M.65, L.74, L.93, T.95, R.96, M.98, L.150 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:V.28, B:A.49, B:K.51, B:K.51, B:L.74, B:T.95, B:L.150, B:L.150 Hydrogen bonds: B:R.96, B:M.98

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Su, H. et al., Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro. Nat Commun (2025)

Release Date

2025-05-07

Peptides

Receptor-interacting serine/threonine-protein kinase 3: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Receptor-interacting serine/threonine-protein kinase 3

Related Entries With Identical Sequence